The interest in biodegradable polymers in the medical and pharmaceutical field stems from the need for extended sustained release drug delivery systems; and degradable medical devices that do not require human intervention for removal from the body. PEG polymers are ideal candidates as a polymeric backbone, as they have successful applications for wound sealing and healing, controlled drug delivery, and tissue engineering.
Synthetic JenKem PEG derivatives and PEG co-polymers offer several advantages over other biodegradable polymers:
[unordered_list style=”bullet”]
- Highly hydrophilic
- Facile introduction of functional groups for drug attachment
- Production of JenKem PEGs back-integrated to ethylene oxide raw material
- Predictable lot-to-lot consistency and raw material sourcing
- No immunogenicity issues normally associated with natural polymers [/unordered_list]
Please visit our website for details on applications of biodegradable PEG products.
Polyglutamic acid PEGs
| PEG PRODUCT | PURITY | ITEM DESCRIPTION |
|---|---|---|
| ≥95% | M-PEG-GLU2 Methoxy PEG Di-Glutamic Acid | |
| ≥90% | M-PEG-GLU3 Methoxy PEG Tri-Glutamic Acid |
PolyLactide Multiarm PEGs (4arm PEG PLA)
| PEG PRODUCT | PURITY | ITEM DESCRIPTION |
|---|---|---|
| ≥95% | 4ARM-PEG2500-b-PLA2500, 4arm Polyethylene Glycol Polylactide Block Copolymer, PEG MW 2500, PLA MW 2500 |
PolyLactide Linear PEGs (PLA PEGs)
| PEG PRODUCT | PURITY | ITEM DESCRIPTION |
|---|---|---|
| ≥90% | MPEG5000-b-PLA2500, Methoxy Polyethylene Glycol Polylactide Block Copolymer, PEG MW 5000, PLA MW 2500 | |
| ≥90% | MPEG5000-b-PLA5000, Methoxy Polyethylene Glycol Polylactide Block Copolymer, PEG MW 5000, PLA MW 5000 |
PolyLactide Linear PEG Derivatives (PLA PEG Derivatives)
| PEG PRODUCT | PURITY | ITEM DESCRIPTION |
|---|---|---|
| ≥90% | MAL-PEG5000-b-PLA20K, Maleimide Polyethylene Glycol Polylactide block copolymer, PEG MW 5000, PLA MW 20000, Substitution (Maleimide) ≥ 70% | |
| ≥90% | MAL-PEG2000-b-PLA2000, Maleimide Polyethylene Glycol Polylactide block copolymer, PEG MW 2000, PLA MW 2000, Substitution (Maleimide) ≥ 70% |
PolyCaprolactone Multiarm PEGs (4arm PCL PEGs)
| PEG PRODUCT | PURITY | ITEM DESCRIPTION |
|---|---|---|
| ≥95% | 4ARM-PEG2500-b-PCL2500, 4arm Polyethylene Glycol Polycaprolactone Block Copolymer, PEG MW 2500, PCL MW 2500 |
PolyCaprolactone Linear PEGs (Methoxy PEG PCL)
| PEG PRODUCT | PURITY | ITEM DESCRIPTION |
|---|---|---|
| ≥90% | MPEG2000-b-PCL2000, Methoxy PEG Polycaprolactone Block Copolymer, PEG MW 2000, PCL MW 2000 |
Poly(Lactide-co-glycolide) Linear PEGs (Methoxy PEG PLGA)
| PEG PRODUCT | PURITY | ITEM DESCRIPTION |
|---|---|---|
| >90% | MPEG10K-b-PLGA18K, Methoxy Polyethelyene glycol poly(Lactide-co-glycolide) diblock copolymer, PEG MW 10000, PLGA MW 18000 |
Poly(Lactide-co-glycolide) Linear PEGs (Methoxy PEG PLGA)
| PEG PRODUCT | PURITY | ITEM DESCRIPTION |
|---|---|---|
| >90% | COOH-PEG5000-b-PLGA5000, Carboxyl Polyethelyene glycol poly (Lactide-co-glycolide) diblock copolymer, PEG MW 5000, PLGA MW 5000 |
Poly(L-lysine) Linear PEGs (Methoxy PEG PLL)
| PEG PRODUCT | Main peak fraction (wt%) | ITEM DESCRIPTION |
|---|---|---|
| ≥90% | PLL20K-G35-PEG2K, PEG-Poly(L-lysine), Poly(L-lysine), Graft Ratio 3.5, PLL MW 20000, PEG MW 2000 |
To learn about additional applications of JenKem Technology PEGs, please visit our website.